Basal cell carcinoma: review of the literature on a case report

Main Article Content

María Erika Boza Medrano
Juan José Gallegos Quezada
Lorena Estefani Alfaro García
Giovanna Aldonza Rios López
Andrea Sierra Franco

Abstract

Basal cell carcinoma is the most common malignant neoplasm of the skin in humans, originating from the basal cells of the epidermis and its adnexa. It is characterized histologically by the uncontrolled proliferation of cells that show similarity to normal basal cells. Chronic exposure to ultraviolet (UV) radiation is considered the main risk factor in its development, and sun-exposed skin, such as the face and upper extremities, is the most common location for the appearance of this disease.


The clinical presentation of basal cell carcinoma can vary, with different subtypes including nodular, superficial, sclerodermiform and pigmented, among others. Each of these subtypes exhibits distinctive clinical features, such as raised lesions with well-defined borders, flat plaques, fibrous or sclerotic appearance, pigmentation, and presence of ulcers. Variability in clinical appearance can make early and accurate diagnosis difficult, highlighting the importance of a thorough evaluation and consideration of biopsies to confirm the diagnosis.


Although basal cell carcinoma tends to have slow local growth and low metastatic capacity, it can cause significant cosmetic and functional damage when it invades surrounding tissues. Therefore, prompt treatment is essential to prevent complications and limit disease progression. Complete surgical excision, using techniques such as Mohs surgery, is the primary approach in the management of basal cell carcinoma. In addition, additional therapeutic modalities such as radiotherapy, photodynamic therapy and topical application of chemotherapeutic agents may be considered in selected cases.

Article Details

How to Cite
Medrano, M. E. B., Quezada, J. J. G. ., García, L. E. A., López, G. A. R., & Franco, A. S. . (2023). Basal cell carcinoma: review of the literature on a case report. International Journal of Medical Science and Clinical Research Studies, 3(06), 1150–1152. https://doi.org/10.47191/ijmscrs/v3-i6-22
Section
Articles

References

I. Acosta A, Rueda X. Therapeutic indications of basal cell and squamous cell carcinoma according to risk factors. In: Cirugía Plástica, reconstructiva y estética de cabeza y cuello. 3rd ed. Volume 2. Colombia: Amolca; 2008. p. 965-84.

II. Arenas R. The skin. Atlas Dermatology Diagnosis and Treatment. 5th ed. Mexico: Editorial Mc Graw Hill Interamericana; 2012. p. 745-49.

III. Porras N, Norris-Squirrell F. Surgical excision of basal cell carcinoma of the scalp. Dermatol RevMex [Internet]. 2016 [cited 2 Feb 2017];60:51-54. Available from: http://www.medigraphic.com/pdfs/derreumex/rmd_2016/rmd161h.pdf

IV. Gaviria Uribe A, Ruiz Gómez F, Muñoz Muñoz NJ. Clinical Practice Guideline with economic evaluation for the prevention, diagnosis, treatment and follow-up of non-melanoma skin cancer: basal cell carcinoma. Complete guide for use by health professionals [Internet]. ;33:32-123. Available from: https://www.gpc.minsalud.gov.co/guias/documents/Cancer%2520Basocelular/GUIA% 2520CARCINOMA%2520BASOCELLULAR-%2520PROFESSIONALS.pdf.

V. Gutiérrez Vidrio RM. Skin cancer. Revista Fac Med UNAM [Internet]. 2003 [cited 15 Dec 2015];46(4). Available from: https://www-ejournal.unam.mx/rfm/no464/RFM46411.pdf

VI. Andrews. Clinical Dermatology. Nevus, neoplasms and epidermal cysts. Vol. II. Madrid, Spain: Mc Graw Hill Interamericana; 2014. p. 820-29.

VII. Fitzpatrick's, Wolff K, Richard A. Color Atlas and Synopsis of Clinical Dermatology.7th ed. Madrid, Spain: Mc Graw Hill Interamericana; 2013. p. 240-46.

VIII. Mancebo SE, Hu JY, Wang SQ. Sunscreens: A Review of Health Benefits, Regulations, and Controversies. Dermatol Clin. 2014;32(3):427-38. Cited in Pub Med; PMID:24891063.

IX. Ministry of Health Mexico. Guía de Práctica clínica Prevención, Diagnóstico y Tratamiento del Carcinoma Basocelular [Internet]. 2013 [cited 21 Jun 2016]. Available from: https://www.imss.gob.mex/profesionales/guiasclinicas/pagues/guias.aspx

X. Criscione VD, Weinstock MA, Naylor MF. Actinic keratoses: Natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial. Cancer. 2013;115(11):2523-30. Cited in Pub Med; PMID:19382202.

XI. Health Statistical Yearbook. Cuba [Internet]. Havana: MINSAP; 2013. Available at: https://www.files.sld.cu/bvscuba/files/2013/05/anuario_2009e3.pdf

Most read articles by the same author(s)